515 related articles for article (PubMed ID: 31401602)
1. Impact of China's healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study.
Zhu D; Shi X; Nicholas S; Bai Q; He P
BMJ Open; 2019 Aug; 9(8):e029646. PubMed ID: 31401602
[TBL] [Abstract][Full Text] [Related]
2. Effect of healthcare system reforms on public hospitals' revenue structures: Evidence from Beijing, China.
Gao L; Shi L; Meng Q; Kong X; Guo M; Lu F
Soc Sci Med; 2021 Aug; 283():114210. PubMed ID: 34274783
[TBL] [Abstract][Full Text] [Related]
3. Impact of China's Public Hospital Reform on Healthcare Expenditures and Utilization: A Case Study in ZJ Province.
Zhang H; Hu H; Wu C; Yu H; Dong H
PLoS One; 2015; 10(11):e0143130. PubMed ID: 26588244
[TBL] [Abstract][Full Text] [Related]
4. Impacts of price changes on public hospital reforms in China: evidence from 25 million patients at tertiary hospitals.
Zhu D; Shi X; Chen S; Ye X; He P
Health Policy Plan; 2022 Nov; 37(10):1307-1316. PubMed ID: 36057091
[TBL] [Abstract][Full Text] [Related]
5. Impact of the zero-mark-up drug policy on drug-related expenditures and use in public hospitals, 2016-2018: an interrupted time series study in Shaanxi.
Yan K; Yang C; Zhang H; Ye D; Liu S; Chang J; Jiang M; Zhao M; Fang Y
BMJ Open; 2020 Nov; 10(11):e037034. PubMed ID: 33243788
[TBL] [Abstract][Full Text] [Related]
6. Impact of the National Centralized Drug Procurement Policy (4 + 7 policy) on the drug expenditures of patients treated in outpatient and emergency departments in a large tertiary level-A hospital in China: A single centre, interrupted time series.
Lan T; Guan L; Pang X; Li X; Yu Q
J Clin Pharm Ther; 2022 Jan; 47(1):104-111. PubMed ID: 34668203
[TBL] [Abstract][Full Text] [Related]
7. [Trend in medical expenditures for patients with kidney diseases: An analysis from a tertiary hospital in Beijing].
Bi SH; Li ZF; Wang T; Wang Y; Zhang C; Ji H; Shi J
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Nov; 53(1):215-219. PubMed ID: 33550360
[TBL] [Abstract][Full Text] [Related]
8. County Hospital Responses to Funding Reforms in Zhejiang, China: An Interrupted Time-Series Analysis.
Zhang T; Liu J; Wang X; Liu C
Health Syst Reform; 2023 Dec; 9(1):2258770. PubMed ID: 37788424
[TBL] [Abstract][Full Text] [Related]
9. The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China.
Zhang X; Lai H; Zhang L; He J; Fu B; Jin C
BMC Health Serv Res; 2020 Nov; 20(1):1058. PubMed ID: 33225941
[TBL] [Abstract][Full Text] [Related]
10. The effect of the National Essential Medicines Policy on health expenditures and service delivery in Chinese township health centres: evidence from a longitudinal study.
Zhang X; Wu Q; Liu G; Li Y; Gao L; Guo B; Fu W; Hao Y; Cui Y; Huang W; Coyte PC
BMJ Open; 2014 Dec; 4(12):e006471. PubMed ID: 25534214
[TBL] [Abstract][Full Text] [Related]
11. Descriptive Analysis on the Impacts of Universal Zero-Markup Drug Policy on a Chinese Urban Tertiary Hospital.
Tian W; Yuan J; Yang D; Zhang L
PLoS One; 2016; 11(9):e0162795. PubMed ID: 27627811
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of systemic reforms of public hospitals: the Sanming model in China.
Fu H; Li L; Li M; Yang C; Hsiao W
Health Policy Plan; 2017 Oct; 32(8):1135-1145. PubMed ID: 28531288
[TBL] [Abstract][Full Text] [Related]
13. Impact of universal medical insurance system on the accessibility of medical service supply and affordability of patients in China.
Xiong X; Zhang Z; Ren J; Zhang J; Pan X; Zhang L; Gong S; Jin S
PLoS One; 2018; 13(3):e0193273. PubMed ID: 29513712
[TBL] [Abstract][Full Text] [Related]
14. What is the major driver of China's hospital medical expenditure growth? A decomposing analysis.
Yan X; Liu Y; Rao K; Li J
BMJ Open; 2022 Feb; 12(2):e048308. PubMed ID: 35135761
[TBL] [Abstract][Full Text] [Related]
15. Time trends and determinants of pharmaceutical expenditure in China (1990-2009).
Shi L; Yang HY; Cheng G; Meng Q
Pharmacoeconomics; 2014 Mar; 32(3):257-64. PubMed ID: 23827980
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effectiveness of comprehensive drug price reform: a case study from Shihezi city in Western China.
Lin T; Wu Z; Liu M; Wu X; Zhang X
Int J Equity Health; 2020 Aug; 19(1):133. PubMed ID: 32762691
[TBL] [Abstract][Full Text] [Related]
17. Effects of different mark-up drug policies on drug-related expenditures in tertiary public hospitals: an interrupted time series study in Shanghai, China, 2015-2018.
Wang X; Li F; Wang X; Zhang X; Liu C; Wang D; Wang H; Chen Y
Biosci Trends; 2020 Mar; 14(1):16-22. PubMed ID: 32092747
[TBL] [Abstract][Full Text] [Related]
18. Short-term and long-term effects of Sanming healthcare system reform on drug-related expenditures for rural patients with cancer in public hospitals: an interrupted time series analysis using segmented regression model in China.
Fu R; Chen Q; Lin Y; Lin Z; Zheng Z; Hu Z
BMJ Open; 2023 Jan; 13(1):e065586. PubMed ID: 36604122
[TBL] [Abstract][Full Text] [Related]
19. Effects of Chinese medical pricing reform on the structure of hospital revenue and healthcare expenditure in county hospital: an interrupted time series analysis.
Liu M; Jia M; Lin Q; Zhu J; Wang D
BMC Health Serv Res; 2021 Apr; 21(1):385. PubMed ID: 33902578
[TBL] [Abstract][Full Text] [Related]
20. The impacts of the National Medication Price-Negotiated Policy on the financial burden of cancer patients in Shandong province, China: an interrupted time series analysis.
Ding Y; Zheng C; Wei X; Zhang Q; Sun Q
BMC Public Health; 2022 Dec; 22(1):2363. PubMed ID: 36527037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
